ASHA remains an independent, unbiased source of information on sexual health. We are guided by science, not ideology. READ MORE.
ASHA remains an independent, unbiased source of information on sexual health. We are guided by science, not ideology. READ MORE.

FDA Approves First Drug to Treat Low Sexual Desire in Women

flibanserin

The American Sexual Health Association strongly supports the Food and Drug Administration’s (FDA) decision to empower women and their healthcare providers by approving Flibanserin, the first drug to treat low sexual desire in females. Hypoactive sexual desire disorder (HSDD, also known as low sexual desire) is the most commonly reported type of sexual dysfunction in […]